Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial | Zendy

Adam Balen | Zendy; Peter Platteau | Zendy; Anders Nyboe Andersen | Zendy; P. Devroey | Zendy; L. Helmgaard | Zendy; JoanCarles Arce | Zendy

Open Access

Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial

Author(s) -

Adam Balen,

Peter Platteau,

Anders Nyboe Andersen,

P. Devroey,

L. Helmgaard,

JoanCarles Arce

Publication year - 2007

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dem075

Subject(s) - ovulation induction , follicle stimulating hormone , ovulation , infertility , unexplained infertility , gynecology , medicine , anovulation , andrology , pregnancy rate , hormone , endocrinology , biology , luteinizing hormone , pregnancy , polycystic ovary , insulin resistance , insulin , genetics

The objective of this study was to demonstrate non-inferiority of a highly purified urinary follicle stimulating hormone (HP-FSH) preparation compared with a recombinant (rFSH) preparation with respect to ovulation rate (primary end-point).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research